T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients
Stopped early · Phase 2/Phase 3
Conditions studied: Hepatocellular Carcinoma
In brief
This is an international, multicenter, randomized study of intravenous T138067 versus intravenous doxorubicin in hepatocellular carcinoma (liver cancer). Patients can not have been treated before with chemotherapy and surgery is not recommended for their cancer. A total of 750 subjects will be enrolled in this study.
Key facts
- Study ID
- NCT00057382
- Run by
- Tularik
- People needed
- 750
- Starts
- 2003-03-01
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California at San Francisco — San Francisco, California, United States
- VA Medical Center — Miami, Florida, United States
- University of Miami — Miami, Florida, United States
- H. Lee Moffitt Cancer Center — Tampa, Florida, United States
- Loyola University of Chicago — Maywood, Illinois, United States
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
- UT Southwestern Medical Center - Dallas — Dallas, Texas, United States
- Hospital Vera Cruz — Belo Horizonte, Brazil
- Hospital Mater Dei - Departamento de Oncologia — Belo Horizonte, Brazil
- Irmandade Santa Casa de Misericórdia de Porto Alegre - Unidade de Apoio à Pesquisa — Porto Alegre, Brazil
- Hospital das Clínicas da Faculdade de Medicina da USP — São Paulo, Brazil
- Cancer Center, Sun Yat-Sen Unversity — Guangzhou, Guangdong, China
- Guangzhou Nanfang Hospital — Guangzhou, Guangdong, China
- Queen Mary Hospital — Hong Kong, Hong Kong, China
- Nanjing Ba Yi Hospital of PLA — Nanjing, Jiangsu, China
- 1st Affiliated Hospital of Xi An Jiao Tong University — Xi’an, Shanxi, China
- Taipei Veteran General Hospital — Taipei, Taiwan, China
- Chang Gung Memorial Hospital — Taoyuan, Taiwan, China
- Cancer Hospital of Chinese Academy of Medical Science (CAMS) — Beijing, China
- Beijing Cancer Hospital of Peking University — Beijing, China
- Gereral Hospital of PLA — Beijing, China
- Chongqing Southwest Hospital — Chongqing, China
- Prince Wales Hosptial — Hong Kong, China
- The Affiliated Hospital of Medical College Qingdao University — Qingdao, China
- University of Alabama — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.